CEO, Phico Therapeutics
Dr Heather Fairhead is the founder and CEO of Phico Therapeutics, which she set up with seed funding from Cambridge Research and Innovation Limited (CRIL). Heather has a wide range of research experience, encompassing molecular biology, microbiology and biochemistry, gained at the Universities of Nottingham, Sheffield and Cambridge where she is also a regular guest lecturer.
She spent a year in the laboratory of Dr Peter Setlow at the University of Connecticut, US working on the proteins that comprise the core of Phico's antibacterial therapy. Heather has a 1st Class Hons degree in Biotechnology, a PhD in Molecular Microbiology and is a Fellow of the Royal Society of Medicine. Prior to starting her scientific career, Heather gained several years experience working in marketing/sales and business administration for a range of companies including Roneo Vickers, Burberry's and latterly Cambridge Consultants.
Heather featured in the Daily Mail's Top 100 Women of Achievement in 2004, and won the CEN Business Woman of the Year award in 2005, having been runner-up in 2004. Heather is a regular lecturer at the University of Cambridge and Imperial College.